We will find out if Avanafil has been approved by the FDA as a treatment for erectile dysfunction after 29th April. An application has already been submitted in the European Medicine Agency but it is the Food and Drug Administration (FDA) in the US that will be first to make a decision.
Avanafil has a much faster onset than any of the current PDE5 medications on the market and is said to kick in within 15 minutes of administration. There is no doubt that it will have a place on the market but it is going to be difficult to overtake Viagra and Cialis. With Sildenafil (the active ingredient in Viagra) coming off patent next year, Avanafil may also struggle on price – we shall see. We have no doubt that Avanafil will be approved; it is just a question of how large a market share it will be able to develop.